HIV/AIDS HAART
Tat mediates sensitivity to reactive drug metabolites in HIV-infected cells
Published in AIDS Vaccine Week, October 31st, 2005
"Impairment of human immunodeficiency virus (HIV)-infected cells to deal with reactive drug metabolites may be a mechanism for the increased rate of adverse drug reactions seen in AIDS. HIV Tat protein expression may be associated with increased oxidative stress within HIV-infected cells.
"To determine the relationship between expression of HIV Tat and sensitivity to reactive drug metabolites, we studied toxicity of sulfamethoxazole (SMX) and its reactive hydroxylamine intermediate (SMX-HA) in lymphocytes transfected with the HIV tat gene," researchers in Canada...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Vaccine Week
Source: AIDS Vaccine Week (2005-10-31)
More Articles from AIDS Vaccine Week
- HIV/AIDS Vaccine Development
U.S. NIH launches first phase II trial of HIV/AIDS vaccine - Antimicrobials
Plant extracts have antimicrobial activity against HIV-related fungal pathogens - DNA Research
HIV-1 Vpr induces degradation of UNG and SMUG uracil-DNA glycosylases - HIV/AIDS Coinfection
GBV-C inhibition of HIV mediated by CD4 and CD8 T-cell-derived soluble factors - HIV/AIDS Diagnostics
Plasma RT assay is an affordable alternative for HIV viral load determination - HIV/AIDS Drug Development
Protease inhibitors plus mefloquine have marked synergy against HIV-1 - More from this issue of AIDS Vaccine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
